Man Group PLC Blueprint Medicines Corp Transaction History

Man Group PLC

$36 Billion
Q3 2024

A detailed history of Man Group PLC transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Man Group PLC holds 518,616 shares of BPMC stock, worth $49.5 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares

518,616

Previous 392,898 32.0%

Holding current value

$49.5 Million

Previous $42.3 Million 13.24%

% of portfolio

0.13%

Previous 0.11%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$84.1 - $120.5 $10.6 Million - $15.1 Million	125,718 Added 32.0%	518,616 $48 Million
Q2 2024 Aug 14, 2024	SELL	$85.18 - $108.78 $1.36 Million - $1.74 Million	-15,982 Reduced 3.91%	392,898 $42.3 Million
Q1 2024 May 15, 2024	BUY	$73.17 - $99.79 $2.25 Million - $3.08 Million	30,816 Added 8.15%	408,880 $38.8 Million
Q4 2023 Feb 14, 2024	BUY	$43.96 - $92.84 $16.6 Million - $35.1 Million	378,064 New	378,064 $34.9 Million
Q1 2023 May 15, 2023	BUY	$37.97 - $50.0 $4.77 Million - $6.28 Million	125,582 Added 1817.13%	132,493 $5.96 Million
Q4 2022 Feb 14, 2023	SELL	$41.06 - $66.48 $1.46 Million - $2.37 Million	-35,629 Reduced 83.75%	6,911 $302,000
Q3 2022 Nov 14, 2022	BUY	$49.93 - $77.7 $2.12 Million - $3.31 Million	42,540 New	42,540 $2.8 Million
Q1 2022 May 16, 2022	SELL	$54.1 - $110.08 $2.32 Million - $4.71 Million	-42,797 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$94.25 - $115.99 $1.62 Million - $2 Million	-17,238 Reduced 28.71%	42,797 $4.58 Million
Q3 2021 Nov 15, 2021	SELL	$80.98 - $109.47 $45,186 - $61,084	-558 Reduced 0.92%	60,035 $6.17 Million
Q2 2021 Aug 16, 2021	BUY	$82.78 - $101.0 $3.8 Million - $4.63 Million	45,847 Added 310.91%	60,593 $5.33 Million
Q1 2021 May 17, 2021	SELL	$90.71 - $108.28 $4.9 Million - $5.85 Million	-54,067 Reduced 78.57%	14,746 $1.43 Million
Q4 2020 Feb 16, 2021	SELL	$92.08 - $124.48 $1.95 Million - $2.64 Million	-21,186 Reduced 23.54%	68,813 $7.72 Million
Q3 2020 Nov 16, 2020	SELL	$66.45 - $92.7 $1.48 Million - $2.06 Million	-22,233 Reduced 19.81%	89,999 $8.34 Million
Q2 2020 Aug 14, 2020	BUY	$57.09 - $79.27 $1.93 Million - $2.69 Million	33,880 Added 43.24%	112,232 $8.75 Million
Q1 2020 May 15, 2020	BUY	$48.11 - $82.22 $2.45 Million - $4.19 Million	50,915 Added 185.57%	78,352 $4.58 Million
Q4 2019 Feb 18, 2020	SELL	$66.73 - $82.59 $1.12 Million - $1.38 Million	-16,758 Reduced 37.92%	27,437 $2.2 Million
Q3 2019 Nov 14, 2019	SELL	$72.9 - $101.41 $641,592 - $892,509	-8,801 Reduced 16.61%	44,195 $3.25 Million
Q2 2019 Aug 14, 2019	BUY	$73.54 - $97.8 $3.1 Million - $4.12 Million	42,147 Added 388.49%	52,996 $5 Million
Q1 2019 May 15, 2019	BUY	$48.7 - $86.6 $210,091 - $373,592	4,314 Added 66.01%	10,849 $868,000
Q4 2018 Feb 14, 2019	SELL	$45.57 - $74.26 $563,700 - $918,596	-12,370 Reduced 65.43%	6,535 $352,000
Q3 2018 Nov 14, 2018	SELL	$58.91 - $78.32 $2.34 Million - $3.11 Million	-39,676 Reduced 67.73%	18,905 $1.48 Million
Q2 2018 Aug 14, 2018	BUY	$60.96 - $101.18 $3.57 Million - $5.93 Million	58,581 New	58,581 $3.72 Million

Others Institutions Holding BPMC

# of Institutions

352

Shares Held

60.3M

Call Options Held

2.25M

Put Options Held

1.18M

View Full List

About Blueprint Medicines Corp

Ticker BPMC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,719,600
Market Cap $5.7B
Description
Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...

More about BPMC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Man Group PLC with notifications on news.

Account